Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant Recipients
Stopped Due in part, to reduced transplant volume and enrollment has been difficult.
Conditions
- Cardiac Allograft Vasculopathy
Interventions
- DRUG: Sirolimus
- DRUG: Sirolimus
- DRUG: Sirolimus
- DRUG: Sirolimus
- DRUG: Sirolimus
Sponsor
University of Minnesota